Bristol-Myers ($BMY) announced the FDA has approved Opdivo for treating advanced renal cell carcinoma in patients who have received prior anti-angiogeneric therapy. J.M. Smucker ($SJM) announced a selling shareholder will offer 2.86 million shares of its common stock in a secondary offering.